Form 4: GTCR Funds Divest 12M Sotera Health Shares in Secondary Offering

GTCR Investment XI LLC and affiliated funds sold 12 million shares of Sotera Health Co common stock for $15.651 per share in a public secondary offering.

Summary

• GTCR Investment XI LLC and its affiliated GTCR XI Funds, which include GTCR Fund XI/A LP, GTCR Fund XI/C LP, and GTCR Co-Invest XI LP, sold a total of 12,000,000 shares of Sotera Health Company's Common Stock.
• The sale occurred on November 10, 2025, as part of an underwritten public secondary offering.
• The shares were sold at a price of $15.651 per share.
• Following this transaction, the GTCR XI Funds beneficially own 29,215,301 shares of Sotera Health Co Common Stock.
• The GTCR entities are identified as both a Director and a 10% Owner of Sotera Health Co.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant insider sale by a major institutional investor and director, which can signal reduced confidence or a strategic exit, potentially impacting the stock price negatively.

Negatives

• A significant sale of 12,000,000 shares by a major institutional investor and director (GTCR) could be interpreted by the market as a reduction in confidence or a strategic divestment, potentially putting downward pressure on the stock price.
• The proceeds from this secondary offering go to the selling shareholders (GTCR entities) and not to Sotera Health Company, meaning the company does not receive any capital from this transaction.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Sotera Health Company management regarding future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This transaction represents a significant divestment by a private equity firm (GTCR) that has historically been a major shareholder and director in Sotera Health. Such sales are common as private equity investors seek to realize returns on their investments, but the scale of the sale can influence market perception of the company's future prospects within its industry.

Stakeholder Impact

• Shareholders: Existing shareholders may experience downward pressure on the stock price due to the large volume of shares sold and the potential negative signal from a major insider's divestment.
• Investors: Potential investors may view this transaction as a cautionary signal, prompting further due diligence into the reasons behind GTCR's significant reduction in ownership.

Key Dates

Recommendation

A significant reduction in ownership by a major institutional investor and director, such as GTCR's sale of 12 million shares, often indicates a bearish outlook or a strategic decision to divest. This action can create substantial selling pressure and signal a lack of confidence in the company's future performance, making a 'sell' recommendation appropriate for investors considering the immediate implications of this insider transaction.

Keywords

Sotera Health, SHC, GTCR, insider sale, secondary offering, beneficial ownership, stock divestment, private equity